
Currently out of the existing stock ratings of Chase Knickerbocker, 92 are a BUY (97.87%), 2 are a HOLD (2.13%).
Analyst Chase Knickerbocker, currently employed at CRAIG HALLUM, has had 44.04% of price targets met with an average potential upside of 53.12%, reached in 185 days on average.
Chase Knickerbocker has documented 183 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MDXG, MiMedx Group at 27-Aug-2026.
Analyst best performing recommendations are on ETON (ETON PHARMACEUTICALS).
The best stock recommendation documented was for IRWD (IRONWOOD PHARMACEUTICALS) on 10/29/2025. The price target of $1.7 was fulfilled within 2 days with a profit of $0.19 (12.58%), with a performance score of 62.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Dec-2022
$12
$12
2 years 1 months 26 days ago
(26-Sep-2024)
1/3 (33.33%)
$8.93 (290.88%)
3
Buy Since 26-Sep-2024
$8
2 years 1 months 26 days ago
(26-Sep-2024)
0/1 (0%)
$4.93 (160.59%)
Buy
$2.5
3 years 9 months 6 days ago
(15-Feb-2023)
1/1 (100%)
$1.86 (290.63%)
145
Buy Since 18-Jul-2019
$29.41
$30
4 years 4 months 30 days ago
(22-Jun-2022)
0/5 (0%)
$24 (443.62%)
Buy Since 09-Jul-2019
$12
$144
6 years 2 months 19 days ago
(02-Sep-2020)
1/2 (50%)
$1.58 (15.16%)
19
Which stock is Chase Knickerbocker most bullish on?
Which stock is Chase Knickerbocker most reserved on?
What Year was the first public recommendation made by Chase Knickerbocker?